Clinical Trials Browser

Expanded_access × Neoplasm Metastasis × 1 year × Clear all

NCT05162443 2025-08-26

Expanded Access of Adagrasib (MRTX849) in Patients With Advanced Solid Tumors Who Have a KRAS G12C Mutation

Approved for marketing

Neoplasm Metastasis, Neoplasms

NCT05650476 2025-06-12

Pre-approval Single-patient Expanded Access for Talazoparib (PF-06944076)

Neoplasm Metastasis, Prostatic Neoplasms